Nasal cavity carcinogenesis by N-nitrosamines: A critical appraisal

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 380, Issue 1-2, 1997, Pages 13-18

  Schuller, Hildegard M ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; NEUROTRANSMITTER RECEPTOR; NITROSAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; HISTOCHEMISTRY; LUNG TUMOR; METABOLITE; NONHUMAN; NOSE CAVITY; NOSE CAVITY TUMOR; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SECRETORY CELL;

ANIMALS; CRICETINAE; DNA ADDUCTS; NITROSAMINES; NOSE NEOPLASMS; ORGAN SPECIFICITY; RATS;

ANIMALIA; RODENTIA;

EID: 0030720026     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00122-X     Document Type: Article

References (35)

1. H. Bartsch, I.K. O'Neill, R. Schulte-Hermann, Relevance of N-nitroso compounds to human cancer: Overview, in: Relevance of N-nitroso Compounds for Human Cancer. IARC, Lyon, IARC Sci. Publ. 84, 1987, pp. 5-10.
2. Hecht S.S., Castonguay A., Rivenson A., Mu B., Hoffman D. Tobacco-specific nitrosamines: carcinogenicity, metabolism, and possible role in human carcinogenesis. J. Environ. Health. C1:1984;1-54.
3. Yang S., Tuly Y., Koop D.R., Coon J. Metabolism of nitrosamines by purified rabbit liver cytochrome P450 isozymes. Cancer Res. 45:1992;1140-1145.
4. Falzon M., McMahon J.B., Gazdar A.F., Schuller H.M. Preferential metabolism of N-nitrosodiethylamine by two cell lines derived from human pulmonary adenocarcinomas. Carcinogenesis. 7:1986;17-22.
5. Hegedus T.J., Falzon M., Margaretten N., Gazdar A.F., Schuller H.M. Inhibition of N-nitrosodiethylamine metabolism in human lung cancer cell lines with features of well differentiated pulmonary neuroendocrine cells. Biochem. Pharmacol. 36:1987;3339-3343.
6. Hecht S.S., Trushin N., Castonguay A., Rivenson A. Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanon and N-nitrosodimethylamine. Cancer Res. 46:1986;498-502.
7. Belynsky S.A., Devereux T.R., Maranpot R.R., Stoner G.D., Anderson M.W. Relationship between the formation of promutagenic adducts and the activation of Ki-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res. 49:1989;5305-5311.
8. Mitsudomi T., Viallet J., Mulshine J.L., Linnoila I.R., Minna J.D., Gazdar A.F. Mutations of ras genes distinguish a subset of non-small cell lung cancer cell lines from small cell lung cancer cell lines. Oncogene. 6:1991;1353-1362.
9. Oreffo V.I.C., Lin H.W., Gumerlok P.H., Kragel S.A., Witschi H.-P. Mutational analysis of dominant oncogene (c-Ki-ras-2) and a tumor suppressor gene (p53) in hamster lung tumourigenesis. Mol. Carcinogen. 6:1992;199-202.
10. H.M. Reznik-Schuller, Nitrosamine-induced nasal cavity carcinogenesis, in: G. Reznik, S.F. Stinson (Eds.), Nasal Tumors in Animals and Man, CRC Press, Boca Raton, FL, 1983, pp. 47-78.
11. A. Rivenson, K. Furuya, S.S. Hecht, D. Hoffman, Experimental nasal cavity tumors by tobacco-specific nitrosamines, in: G. Reznik, S.F. Stinson (Eds.), Nasal Tumors in Animals and Man, CRC Press, Boca Raton, FL, 1983, pp. 79-114.
12. H. Bartels, The human lung, in: H.M. Reznik-Schuller (Ed.), Comparative Respiratory Tract Carcinogenesis, CRC Press, Boca Raton, FL, 1983, pp. 19-54.
13. H.M. Reznik-Schüller, The respiratory tract in rodents, in: H.M. Reznik-Schuller (Ed.), Comparative Respiratory Tract Carcinogenesis, CRC Press, Boca Raton, FL, 1983, pp. 79-116.
14. H.M. Schuller, M. Gregg, G.K. Reznik, Tumors of the nasal cavity in rats, in: V.S. Turusov, U. Mohr (Eds.), Pathology of Tumors in Laboratory Animals. Vol. I, Tumors of the Rat, IARC, Lyon, IARC Sci. Publ. 99, 1990, pp. 259-274.
15. G.K. Reznik, H.M. Schuller, S.F. Stinson, Tumors of the nasal cavity in the mouse, in: Pathology of Tumors in Laboratory Animals, IARC, Lyon, IARC Sci. Publ. 111, 1994, pp. 342-363.
16. H.M. Schuller, Tumors of the nasal cavity in hamsters, in: Pathology of Tumors in Laboratory Animals, IARC, Lyon, IARC Sci. Publ. 112, 1995, pp. 169-181.
17. Reznik-Schüller H.M. Pathogenesis of tumors induced with N-nitrosomethylpiperazine in the olfactory region of the rat nasal cavity. J. Natl. Cancer Inst. 71:1983;165-172.
18. Lijinsky W. Species differences in nitrosamine carcinogenesis. J. Cancer Res. Clin. Oncol. 108:1984;46-55.
19. Brittebo E.B., Tjälve H. Formation of tissue-bound N-nitrosonor-nicotine metabolites by the target tissues of Sprague Dawley and Fisher rats. Carcinogenesis. 2:1981;959-963.
20. E.B. Brittebo, H. Tjälve, Metabolism of N-nitrosamines by nasal mucosa, in: G. Reznik, S.F. Stinson (Eds.), Nasal Tumors in Animals and Man, CRC Press, Boca Raton, FL, 1983, pp. 233-250.
21. E.B. Brittebo, Uptake and irreversible binding of xenobiotics in the nasal mucosa, in: V.J. Feron, M.C. Bosland (Eds.), Nasal Carcinogenesis in Rodents, Pudoc, Wageningen, 1989, pp. 119-124.
22. Reznik-Schüller H.M. Labelling in cells of the nasal cavity of hamsters treated with tritiated N-nitrosodiethylamine. Cancer Lett. 16:1982;109-114.
23. Van Benthem J., Wild C.P., Vermeulen E., Den Engelse L., Scherer E. Immunocytochemical localization of DNA adducts induced by a single dose of N-nitroso-N-methylbenzylamine in target and non-target tissues of tumor formation in the rat. Carcinogenesis. 12:1991;1831-1837.
24. 6-and 7-methylguanine in DNA of N-nitroso-N-methylbenzylamine-treated rats is restricted to non-target organs for N-nitroso-N-methylbenzylamine-induced carcinogenesis. Carcinogenesis. 13:1992;2101-2105.
25. J. Van Benthem, J.W.G.M. Wilmer, H.H.K. Winterwerp, W.R. Leeman, E. Scherer, L. Den Engelse, Immunocytochemical study of formation and repair of NNK-induced DNA-adducts in nasal epithelium, in: V.J. Feron, M.C. Bosland (Eds.), Nasal Carcinogeneis in Rodents: Relevance to Human Health Risk, Pudoc, Wageningen, 1989, pp. 152-158.
26. S.A. Belinsky, V.E. Walker, L.C. Uraih, R.R. Maranpot, J.A. Swenberg, M.W. Anderson, Role of DNA-adduct formation and cell proliferation in the induction of nasal tumors in the rat by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in: V.J. Feron, M.C. Bosland (Eds.), Nasal Carcinogenesis in Rodents: Relevance to Human Health Risk, Pudoc, Wageningen, 1989, pp. 146-151.
27. Ward J.M., Uno H., Kurata Y., Weghorst C.M., Jang J.-J. Cell proliferation not associated with carcinogenesis in rodents and humans. Environ. Health Perspect. 101(Suppl. 5):1993;125-136.
28. Nylen E.S., Snider R.H., Moore C.F., Becker K.L. Modulation of pulmonary bombesin by nicotine and vagotomy. Life Sci. 47:1990;213-218.
29. Schuller H.M., Hegedus T.J. Effects of endogenous and tobacco-related amines and nitrosamines on cell growth and morphology of a cell line derived from a human neuroendocrine lung cancer. In Vitro Toxicol. 3:1989;37-43.
30. Schuller H.M. Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem. Pharmacol. 38:1989;3439-3442.
31. Schuller H.M. Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways. Neurotoxicology. 15:1994;877-886.
32. Cattaneo M.G., Codignola A., Vicenti L.M., Clementi F., Sher E. Nicotine stimulates a serotonergic autocrine loop in human small cell carcinoma. Cancer Res. 53:1993;5566-5568.
33. Siegfried G.M., Guentert P.J., Gaither A.L. Effects of bombesin and gastrin-releasing peptide on human bronchial epithelial cells from a series of donors: individual variation and modulation by bombesin analogues. Anat. Rec. 236:1993;241-247.
34. 2 on neuroendocrine cell proliferation mediated by nicotinic receptor stimulation: Significance for the lung cancer risk in individuals with chronic lung disease. Chest. 109(Suppl):1996;20S-21S.
35. 2+/calmodulin. Cancer. Res. 50:1990;1645-1649.